Catherine E. Devine, M.D.
Department of Abdominal Imaging, Division of Diagnostic Imaging
About Dr. Catherine E. Devine
Dr. Devine obtained her M.D. from The University of Texas-Health Science center in 1999. She performed a year internship at Christus-St. Joseph Hospital, Houston, Texas, followed by a residency in Diagnostic Radiology at The University of Texas-Health Science Center, 2000-2004. Dr. Devine completed a fellowship in Abdominal Imaging at The University of Texas MD Anderson Cancer Center in 2005, and was subsequently appointed to a faculty position. Dr. Devine is currently a Professor of the Department of Abdominal Imaging in the Division of Diagnostic Imaging.
Present Title & Affiliation
Primary Appointment
Professor, Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Professor, Diagnostic Radiology, The University of Texas-Houston Medical School, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Research Interests
Melanoma
Genitourinary Malignancies
Gastric Cancer
Clinical Interests
CT
MRI
PET/CT
US
GI
US Guided Biopsies
Education & Training
Degree-Granting Education
| 1999 | University of Texas Health Science Center at Houston, Houston, Texas, US, MD |
| 1994 | Texas A&M University, College Station, Texas, US, Biomedical Science, BS |
Postgraduate Training
| 2004-2005 | Clinical Fellowship, Body Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2000-2004 | Clinical Residency, Diagnostic Radiology, The University of Texas-Houston Medical School, Houston, Texas |
| 1999-2000 | Clinical Internship, Medicine, Christus St. Joseph Hospital, Houston, Texas |
Licenses & Certifications
| 2004 | American Board of Radiology |
| 2003 | State Board of Medical Examiners |
Experience & Service
Faculty Academic Appointments
Associate Professor, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2020
Assistant Professor, Diagnostic Radiology, The University of Texas-Houston Medical School, Houston, TX, 2005 - 2011
Assistant Professor, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005 - 2011
Administrative Appointments/Responsibilities
Department Chair ad interim, Abdominal Imaging Department, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2025 - Present
Department Wellness Advocate, Abdominal Imaging Department, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - 2026
Department Chair ad interim, Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2023
Co-Section Chief, Ad Interim, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019
Physician Champion-Advanced Practice Provider Program, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - Present
Co-Chair, Positron Emission Tomography/Computed Tomography Leadership Team, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2022
Co-Director, Abdominal Imaging Operations Review Committee, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2015
Abdominal Imaging Section Scheduler, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2015
Other Professional Positions
Question rater, American Board of Radiology OLA, Tucson, AZ, 2020 - Present
Extramural Institutional Committee Activities
Member, GI Medical Oncology Department Chair Search Committee, The University of Texas MD Anderson Cancer Center, 2026 - Present
Member, Urology Department Chair Search Committee, The University of Texas MD Anderson Cancer Center, 2024 - 2025
Member, DI Deputy Division Head of Operations Search/Advisory committee, The University of Texas MD Anderson Cancer Center, 2022 - 2022
Search Committee Member, Chair, Department of Gastroenterology, Hepatology and Nutrition Search Committee, The University of Texas MD Anderson Cancer Center, 2021 - 2022
Faculty Subcommittee Lead, Endemic Operations Optimizing Leave Initiative, The University of Texas MD Anderson Cancer Center, 2020 - 2022
Member, DI-Research Functional Committee Industry Strategic Partnership (ISC) sub-committee, The University of Texas MD Anderson Cancer Center, 2020 - 2023
Member, Diagnostic Radiology Research Seminar Series Planning Committee, The University of Texas MD Anderson Cancer Center, 2019 - 2023
Member, Abdominal Imaging Clinical Operations Advisory Group, The University of Texas MD Anderson Cancer Center, 2018 - 2023
Member, Abdominal Imaging Leadership Council, The University of Texas MD Anderson Cancer Center, 2018 - 2023
Member, Interview Panel for Diagnostic Imaging Quality Officer, The University of Texas MD Anderson Cancer Center, 2017 - 2018
Co-Officer, Diagnostic Radiology Quality & Safety, The University of Texas MD Anderson Cancer Center, 2016 - 2018
Member, Diagnostic Imaging Faculty Development Subcommittee, The University of Texas MD Anderson Cancer Center, 2015 - 2023
Member, Diagnostic Imaging Clinic Physician Communication Committee, The University of Texas MD Anderson Cancer Center, 2015 - 2017
Member, Diagnostic Radiology Timely Reading of Exams Subcommittee, The University of Texas MD Anderson Cancer Center, 2015 - 2017
Volunteer, Focus Area of Strategic Plan, The University of Texas MD Anderson Cancer Center, 2014 - Present
Member, Diagnostic Imaging Clinical Functional Committee, The University of Texas MD Anderson Cancer Center, 2013 - Present
Member, Clinical Operations Functional Committee Subcommittee American Board of Radiology/American College of Radiology Task Force, The University of Texas MD Anderson Cancer Center, 2013 - 2015
Member, Body Section Policy Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2014
Member, Diagnostic Imaging Computed Tomography Equipment Panel, The University of Texas MD Anderson Cancer Center, 2013 - 2014
Member, Ultrasound in the New Millennium, The University of Texas MD Anderson Cancer Center, 2013
Member, Clinical Ultrasound Advisory Group, The University of Texas MD Anderson Cancer Center, 2012 - Present
Alternate, Professional Liability Committee, The University of Texas MD Anderson Cancer Center, 2012 - Present
Alternate, Diagnostic Radiology Executive Committee, The University of Texas MD Anderson Cancer Center, 2012 - 2015
Member, Division of Diagnostic Imaging, Body Quality Assurance Peer Review Committee, The University of Texas MD Anderson Cancer Center, 2011 - Present
Member, Radiology Information System Redesign Project-Radiologists Workflow-Body Section representative, The University of Texas MD Anderson Cancer Center, 2010 - 2011
Member, Computed Tomography Workflow Committee, The University of Texas MD Anderson Cancer Center, 2009 - 2010
Member, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2007 - 2010
Alternate, Credentials Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 2007 - 2009
Member, Quality Improvement Peer Review Committee, The University of Texas MD Anderson Cancer Center, 2007 - 2008
Member, Search for Body Imaging Section Chief, The University of Texas MD Anderson Cancer Center, 2007 - 2008
Honors & Awards
| 2018 | Certificate of Merit, Digital Education Exhibit, Multimodality imaging spectrum of desmoid-type fibromatosis tumors and associated syndromes and genetics, Radiological Society of North America |
| 2013 | Certificate of Merit, Education Exhibit, Changes in pelvic anatomy following pelvic exenteration, imaging findings pelvic exenteration for pelvic malignancies: A systematic review, Radiological Society of North America |
| 2013 | Certificate of Merit, Education Exhibit, The role of intra-operative ultrasound in oncologic therapy, Radiological Society of North America |
| 2011 | Certificate of Merit, Education Exhibit, Imaging of the gall bladder wall: A pattern recognition approach on CT and MRI with pathologic correlation, Radiological Society of North America |
| 2004 | Certificate of Merit, Education Exhibit, Imaging characteristics of local recurrent primary tumors of bone, Radiological Society of North America |
| 2002 | Summa Cum Laude, American Society of Neuroradiology |
| 1998 | Alpha Omega Alpha |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2025. Imaging for diagnosis and staging of gastric/GEJ cancer. Invited. AstraZeneca Advanced Scientific Workshop. Houston, Texas, US.
- 2019. MD Anderson Multidisciplinary Care Discussion Panel. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2013. Liver and gallbladder ultrasound: Case studies. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
National Presentations
- 2020. Quality Improvement and Troubleshooting in Rectal MRI - How We Do It. Conference. Proceedings of 106th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2016. Dual energy CT for evaluation of vascular anatomy in patients with hepatobiliary and pancreatic cancer. Conference. Society of Abdominal Radiology. Waikoloa, HI, US.
- 2014. BRCA associated tumors—not just breast and ovarian cancer. Conference. 100th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2014. Metastatic melanoma: Pictorial review of the usual and unusual faces of the serious tumor. Conference. 100th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2014. The ultimate guide to the journey of IPMNs: From simple cyst to widespread metastases. Conference. 100th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2014. Hepatobiliary and pancreatic vascular anatomy in the era of Dual Energy CT (DECT). Conference. 100th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2013. Changes in pelvic anatomy following pelvic exenteration, imaging findings pelvic exenteration for pelvic malignancies: A systematic review. Conference. 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2013. The role of intra-operative ultrasound in oncologic therapy. Conference. 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2013. Is second-line targeted therapy beneficial in patients (pts) with differentiated thyroid cancer (DTC) after first-line sorafenib (SOR) failure?. Conference. 13th Annual Meeting of the American Society of Clinical Oncology. Chicago, IL, US.
- 2011. Imaging of the gallbladder wall: a pattern recognition approach on CT and MRI with pathologic correlation. Conference. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2011. Ovarian metastases from colon carcinoma. Conference. 111th Annual Meeting of the American Roentgen Ray Society. Chicago, IL, US.
- 2010. What is the clinical significance of FDG uptake in the prostate in a patient undergoing a PET/CT?. Conference. 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2010. How well do radiologists remember test images?. Conference. 109th Annual Meeting of the American Roentgen Ray Society. San Diego, CA, US.
- 2008. Ovarian cancer screening: Unmasking the corpus luteum and other actors--how to sort them out. Conference. 108th Annual Meeting of the American Roentgen Ray Society. Washington, DC, US.
- 2004. Imaging characteristics of locally recurrent primary tumors of bone. Conference. 90th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2002. Correlating the basic pathophysiologic neuronal changes in response to ischemia with multisequence MR imaging. Conference. American Society of Neuroradiology Annual Meeting. Vancouver, CA.
International Presentations
- 2019. The rich diversity of SMARCB1-Deficient tumors: The seminal role of SMARCB1/INI 1 tumor suppressor gene in the pathogenesis of unique rhabdoid tumors. Conference. European Society of Gastrointestinal and Abdominal Radiology 30th Annual Meeting and Postgraduate Course. Rome, IT.
- 2017. Thyroglobulin does not correlate with response in radioactive iodine refractory (RAIR) BRAF mutated papillary thyroid cancer (PTC) treated with dabrafenib alone or in combination with trametinib. Conference. 87th Annual Meeting of the American Thyroid Association. Victoria, CA.
Selected Publications
Peer-Reviewed Articles
- Vassilakopoulou M, Chen HC, Wang X, Harada K, Iwatsuki M, Das P, Blum Murphy M, Matamoros A, Sagebiel T, Devine CE, Thomas I, Sanders EM, Shanbhag N, Rogers JE, Lee JH, Weston B, Bhutani MS, Hofstetter W, Nguyen QN, Badgwell BD, Ajani JA. Localized gastroesophageal adenocarcinoma in the elderly: is age a factor associated with suboptimal treatment?. Oncology 101(3):153-158, 2023. e-Pub 2023. PMID: 36412619.
- Busaidy NL, Konda B, Wei L, Wirth LJ, Devine CE, Daniels GA, DeSouza JA, Poi M, Seligson ND, Cabanillas ME, Sipos JA, Ringel MD, Eisfeld AK, Timmers C, Shah MH. Dabrafenib Versus Dabrafenib + Trametinib in BRAF-Mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer: Results of a Randomized, Phase 2, Open-Label Multicenter Trial. Thyroid 32(10):1184-1192, 2022. e-Pub 2022. PMID: 35658604.
- Virarkar M, Jensen C, Klekers A, Wagner-Bartak NA, Devine CE, Lano EA, Sun J, Tharakeswara B, Bhosale P. Clinical importance of second-opinion interpretations of abdominal imaging studies in a cancer hospital and its impact on patient management. Clin Imaging 86:13-19, 2022. e-Pub 2022. PMID: 35313164.
- Segaran N, Devine CE, Wang M, Ganeshan D. Current update on imaging for pancreatic neuroendocrine neoplasms. World Journal of Clinical Oncology, 2021. e-Pub 2021.
- Segaran N, Sandrasegaran K, Devine CE, Wang MX, Shah C, Ganeshan D. Features of primary pancreatic lymphoma: A bi-institutional review with an emphasis on typical and atypical imaging features. World J Clin Oncol 12(9):823-832, 2021. e-Pub 2021. PMID: 34631445.
- Abdelhakeem A, Patnana M, Wang X, Rogers JE, Murphy MB, Sagebiel T, Ikoma N, Badgwell BD, Trail A, Estrella JS, Lu Y, Devine CE, Ajani JA. Influence of baseline positron emission tomography in metastatic gastroesophageal cancer on survival and response to therapy. Oncology:1-6. e-Pub 2021. PMID: 34352788.
- Borregales LD, Adibi M, Thomas AZ, Reis RB, Chery LJ, Devine CE, Wang X, Potretzke AM, Potretzke T, Figenshau RS, Bauman TM, Aboshady YI, Abel EJ, Matin SF, Karam JA, Wood CG. Predicting adherent perinephric fat using preoperative clinical and radiological factors in patients undergoing partial nephrectomy. Eur Urol Focus 7(2):397-403, 2021. e-Pub 2021. PMID: 31685445.
- Abdelhakeem AA, Wang X, Waters RE, Patnana M, Estrella JS, Blum Murphy M, Trail AM, Lu Y, Devine CE, Ikoma N, Das P, Badgwell BD, Rogers JE, Ajani JA. Preoperatively treated diffuse-type gastric adenocarcinoma: glucose vs. other energy sources substantially influence prognosis and therapy response. Cancers (Basel) 13(3), 2021. e-Pub 2021. PMID: 33498613.
- Go B, Poonia SK, Devine CE, Javia L, Buzi A, Rizzi MD. Two rare cases of sinonasal vascular malformation in the pediatric population. Int J Pediatr Otorhinolaryngol 138:110192, 2020. e-Pub 2020. PMID: 32705987.
- Tannir NM, Msaouel P, Ross JA, Devine CE, Chandramohan A, Gonzalez GMN, Wang X, Wang J, Corn PG, Lim ZD, Pruitt L, Karam JA, Wood CG, Zurita AJ. Temsirolimus versus pazopanib (TemPa) in patients with advanced clear cell renal cell carcinoma and poor-risk features: A randomized phase II trial. Eur Urol Oncol 3(5):687-694, 2020. e-Pub 2020. PMID: 31272939.
- Virarkar M, Ganeshan D, Devine CE, Bassett R, Kuchana V, Bhosale P. Diagnostic value of PET/CT versus PET/MRI in gynecological malignancies of the pelvis: A meta-analysis. Clin Imaging 60(1):53-61, 2020. e-Pub 2020. PMID: 31864201.
- Virarkar M, Devine CE, Bassett R, Javadi S, Faria SC, Bhosale P. Update on diagnostic performance of PET/MRI in gynecological malignancies: a systematic review and meta-analysis. J Belg Soc Radiol 104(1):4, 2020. e-Pub 2020. PMID: 31998862.
- Virakar M, Devine CE, Javadi S, Faria S, Basset R, Bhosale P. Diagnostic performance of PET/MR in gynecological malignancies: A systemic review and meta-analysis, 2020. e-Pub 2020.
- Sagebiel TL, Bhosale PR, Patnana M, Faria SC, Devine CE. Uterine carcinosarcomas. Semin Ultrasound CT MR 40(4):295-301, 2019. e-Pub 2019. PMID: 31375170.
- Marcal L, Patnana M, Yedururi S, Devine CE, Cox V, Dasari A, Chuang H, Loyer E. Abdominal manifestations of neuroendocrine tumors. Dig Dis Interv 03(01):14-29, 2019. e-Pub 2019.
- Curry JL, Tetzlaff MT, Wang SA, Landon G, Alouch N, Patel SP, Nagarajan P, Gupta S, Aung PP, Devine CE, Khoury JD, Loghavi S, Prieto VG, DiNardo CD, Gershenwald JE. Case report of myeloid sarcoma masquerading as in-transit metastasis at a previous melanoma site: Avoiding a diagnostic pitfall. Am J Dermatopathol 40(11):831-835, 2018. e-Pub 2018. PMID: 29863571.
- Mizrak Kaya D, Nogueras-Gonzáles GM, Harada K, Amlashi FG, Thomas I, Rogers JE, Bhutani MS, Lee JH, Weston B, Minsky BD, Estrella JS, Blum Murphy MA, Matamoros A, Devine CE, Das P, Badgwell BD, Ajani JA. Potentially curable gastric adenocarcinoma treated without surgery. Eur J Cancer 98:23-29, 2018. e-Pub 2018. PMID: 29859338.
- Patnana M, Korivi BR, Devine CE, Faria S, Prieto V, Ross M, Ng C. Metastatic melanoma to the testis. Br J Radiol, 2018. e-Pub 2018.
- Ikoma N, Lee JH, Bhutani MS, Ross WA, Weston B, Chiang YJ, Blum MA, Sagebiel T, Devine CE, Matamoros A, Fournier K, Mansfield P, Ajani JA, Badgwell BD. Preoperative accuracy of gastric cancer staging in patient selection for preoperative therapy: Race may affect accuracy of endoscopic ultrasonography. J Gastrointest Oncol 8(6):1009-1017, 2017. e-Pub 2017. PMID: 29299361.
- Ikoma N, Das P, Blum M, Estrella JS, Devine CE, Wang X, Fournier K, Mansfield P, Minsky BD, Ajani J, Badgwell BD. Preoperative chemoradiation therapy does dot increase risk of anastomotic leak in patients with gastric cancer. Int J Radiat Oncol Biol Phys 99(3):660-666, 2017. e-Pub 2017. PMID: 29280460.
- Al-Shamsi HO, Fahmawi Y, Dahbour I, Tabash A, Rogers JE, Mares JE, Blum MA, Estrella J, Matamoros A, Sagebiel T, Devine CE, Badgwell BD, Lin QD, Das P, Ajani JA. Continuation of trastuzumab beyond disease progression in HER2-positive metastatic gastric cancer: The MD Anderson experience. J Gastrointest Oncol 7(4):499-505, 2016. e-Pub 2016. PMID: 27563438.
- Karam JA, Devine CE, Fellman BM, Urbauer DL, Abel EJ, Allaf ME, Bex A, Lane BR, Thompson RH, Wood CG. Variability of inter-observer agreement on feasibility of partial nephrectomy before and after neoadjuvant axitinib for locally advanced renal cell carcinoma (RCC): Independent analysis from a phase II trial. BJU Int 117(4):629-635, 2016. e-Pub 2016. PMID: 26033220.
- Adibi M, Kenney PA, Thomas AZ, Borregales LD, Nogueras-González GM, Wang X, Devine CE, Karam JA, Wood CG. Prediction of pulmonary metastasis in renal cell carcinoma patients with indeterminate pulmonary nodules. Eur Urol 69(2):352-360, 2016. e-Pub 2016. PMID: 26382085.
- Gardner CS, Sunil J, Klopp AH, Devine CE, Sagebiel T, Viswanathan C, Bhosale PR. Primary vaginal cancer: Role of MRI in diagnosis, staging and treatment. Br J Radiol 88(1052):20150033, 2015. e-Pub 2015. PMID: 25966291.
- Sagebiel TL, Viswanathan C, Patnana M, Devine CE, Frumovitz M, Bhosale PR. Overview of the role of imaging in pelvic exenteration. Radiographics 35(4):1286-1294, 2015. e-Pub 2015. PMID: 26172363.
- Faria SC, Sagebiel T, Balachandran A, Devine CE, Lal C, Bhosale PR. Imaging in endometrial carcinoma. Indian J Radiol Imaging 25(2):137-147, 2015. e-Pub 2015. PMID: 25969637.
- Chauhan A, Garg N, Menias CO, Devine CE, Bhosale PR, Balachandran A. Tumor thrombus as a rare presentation of lymphoma: A case series of 14 patients. AJR Am J Roentgenol 204(4):W398-W404, 2015. e-Pub 2015. PMID: 25794089.
- Rauch GM, Eric T, Bhosale P, Devine CE, Rao-Korivi B, Faria S, Szklaruk J. Hepatic and pancreatic vascular anatomy in the era of dual energy CT. e-Pub 2015.
- Karam JA, Devine CE, Urbauer DL, Lozano M, Maity T, Ahrar K, Tamboli P, Tannir NM, Wood CG. Phase 2 trial of neoadjuvant axitinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma. Eur Urol 66(5):874-880, 2014. e-Pub 2014. PMID: 24560330.
- Dadu R, Devine CE, Hernandez M, Waguespack SG, Busaidy NL, Hu MI, Jimenez C, Habra MA, Sellin RV, Ying AK, Cote GJ, Sherman SI, Cabanillas ME. Role of salvage targeted therapy in differentiated thyroid cancer patients who failed first-line sorafenib. J Clin Endocrinol Metab 99(6):2086-2094, 2014. e-Pub 2014. PMID: 24628550.
- Haygood TM, Qing Liu MA, Galvan EM, Bassett R, Devine CE, Lano E, Viswanathan C, Marom EM. Memory for previously viewed radiographs and the effect of prior knowledge of memory task. Acad Radiol 20(12):1598-1603, 2013. e-Pub 2013. PMID: 24200488.
- Ganeshan D, Iyer R, Devine CE, Bhosale P, Paulson E. Imaging of primary and secondary renal lymphoma. AJR Am J Roentgenol 201(5):W712-W719, 2013. e-Pub 2013. PMID: 24147501.
- Viswanathan C, Kirschner K, Truong M, Balachandran A, Devine CE, Bhosale P. Multimodality imaging of vulvar cancer: Staging, therapeutic response, and complications. AJR Am J Roentgenol 200(6):1387-1400, 2013. e-Pub 2013. PMID: 23701080.
- Bhosale P, Peungjesada S, Devine CE, Balachandran A, Iyer R. Role of magnetic resonance imaging as an adjunct to clinical staging in cervical carcinoma. J Comput Assist Tomogr 34(6):855-864, 2010. e-Pub 2010. PMID: 21084900.
- Virarkar M, Aziz A, Wang MX, Sun J, Devine CE, Bhosale P. Metastatic Burden, FIGO Stage, and Apparent Diffusion Coefficient as Prognostic Imaging Biomarkers in Clear Cell Carcinoma of the Uterus and Cervix. Spring Nature.
Invited Articles
- Gao M, Bhosale P, Devine CE, Palmquist S, Javadi S. US, MRI, CT Performance and Interpretation of Uterine Masses. ScienceDirect, 2023. e-Pub 2023.
- Faria SC, Devine CE, Rao B, Sagebiel T, Bhosale P. Imaging and staging of endometrial cancer. Semin Ultrasound CT MR 40(4):287-294, 2019. e-Pub 2019. PMID: 31375169.
- Devine CE, Viswanathan C, Faria SD, Marcal LP, Sagebiel TL. Imaging and staging of cervical cancer. Semin Ultrasound CT MR. e-Pub 2019.
- Devine CE, Gardner C, Sagebiel T, Bhosale P. Magnetic resonance imaging in the diagnosis, staging, and surveillance of cervical carcinoma. Semin Ultrasound CT MR 36(4):361-368, 2015. e-Pub 2015. PMID: 26296486.
- Leursen G, Gardner CS, Sagebiel T, Patnana M, de CastroFaria S, Devine CE, Bhosale PR. Magnetic resonance imaging of benign and malignant uterine neoplasms. Semin Ultrasound CT MR 36(4):348-460, 2015. e-Pub 2015. PMID: 26296485.
- Devine CE, Mawlawi O. Radiation safety with positron emission tomography and computed tomography. Semin Ultrasound CT MR 31(1):39-45, 2010. e-Pub 2010. PMID: 20102694.
- Devine CE, Szklaruk J, Tamm EP. Magnetic resonance imaging in the characterization of pelvic masses. Semin Ultrasound CT MRI 26(3):172-204, 2005. e-Pub 2005. PMID: 15987066.
Review Articles
- Gao, M, Bhosale, PR, Devine, CE, Palmquist, SM, Javadi, S. US, MRI, CT Performance and Interpretation of Uterine Masses. Seminars in Ultrasound, CT and MRI 44(6):541-559, 2023. e-Pub 2023. PMID: 37821051.
- Wang MX, Devine CE, Segaran N, Ganeshan D. Current update on molecular cytogenetics, diagnosis and management of gastrointestinal stromal tumors. World J Gastroenterol 27(41):7125-7133, 2021. e-Pub 2021. PMID: 34887632.
- Ganeshan D, Kambadakone A, Nikolaidis P, Subbiah V, Subbiah IM, Devine CE. Current update on gallbladder carcinoma. Abdom Radiol (NY) 46(6):2474-2489, 2021. e-Pub 2021. PMID: 33386907.
- Wong VK, Ganeshan D, Jensen CT, Devine CE. Imaging and Management of Bladder Cancer. Cancers (Basel) 13(6), 2021. e-Pub 2021. PMID: 33808614.
- Faria S, Devine CE, Viswanathan C, Javadi S, Korivi BR, Bhosale PR. FDG-PET assessment of other gynecologic cancers. PET Clin 13(2):203-223, 2018. e-Pub 2018. PMID: 29482750.
- Viswanathan C, Faria S, Devine CE, Patnana M, Sagebiel T, Iyer RB, Bhosale PR. [18F]-2-Fluoro-2-Deoxy-D-glucose-PET assessment of cervical cancer. PET Clin 13(2):165-177, 2018. e-Pub 2018. PMID: 29482748.
- Iyer RB, Balachandran A, Devine CE. PET/CT and cross sectional imaging of gynecologic malignancy. Cancer Imaging 7 Spec No A:S130-S138, 2007. e-Pub 2007. PMID: 17921092.
Professional Educational Materials
- Mohammad F, Devine CE. Foreign Body. The University of Texas-Houston Medical School, 2009.
- Mohammad F, Devine CE. Foreign Body. American College of Radiology-Case in Point, 2009.
- Devine CE, Mercado MG. Radiographic manifestations of non-accidental trauma. Case Report. Web-based Teaching File. The University of Texas-Houston Medical School, 2004.
- Devine CE, Mercado MG. Congenital diaphragmatic hernia. Case Report. Web Based Teaching File. The University of Texas-Houston Medical School, 2004.
- Devine CE, Oldham SAA. Manifestations of primary TB in an AIDS patient. Case Report. Web Based Teaching File. The University of Texas-Houston Medical School, 2003.
Other Articles
- Konda B, Sukrithan V, Nabhan F, Xu M, Busaidy N, Wirth L, Daniels G, DeSouza J, Devine CE, Cabanillas M, Sipos J, Ringel M, Shah M, Timmers C Circulating biomarkers of response to Dabrafenib alone or in combination with Trametinib in BRAF-Mutated, radioactive Iodine-Refractory well-differentiated and poorly differentiated thyroid cancer. Thyroid.
Abstracts
- Devine CE. Quality improvement and troubleshooting in rectal MRI. Proceedings of 106th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2020. e-Pub 2020.
- Marcal LP, Morani A, Devine CE, Yedururi S, Katabathina V, Prasad S. The rich diversity of SMARCB1-deficient tumors: The seminal role of SMARCB1/INI 1 tumor suppressor gene in the pathogenesis of unique malignant rhabdoid tumors. European Society of Gastrointestinal and Abdominal Radiology 30th Annual Meeting and Postgraduate Course Programme, 2019. e-Pub 2019.
- Faria S, Sagebiel T, Devine CE, Elsherif S, Bura V, Lall C, Kundra V, Bhosale P. Multimodality imaging spectrum of desmoid-type fibromatosis tumors and associated syndromes and genetics. 104th Scientific Assembly and Annual Meeting of the Radiological Society of North America:37-42, 2018. e-Pub 2018.
- Zurita-Saavedra A, Tannir NM, Ross J, Devine CE, Chandramohan A, Wang X, Lim ZD, Wang J, Corn P, Msaouel P. A randomized phase II trial of pazopanib (PAZ) vs. temsirolimus (TEM) in patients (pts) with advanced clear-cell renal cell carcinoma (accRCC) with intermediate or poor-risk disease (the TemPa trial). J Clin Oncol 36(15_suppl), 2018. e-Pub 2018.
- Konda B, Shah MH, Wei L, Espinosa AV, Busaidy NL, Wirth LJ, Daniels GA, De Souza JA, Sexton JL, Beshara M, Liu T, Nichols D, Snyder N, Devine CE, Timmers CD. Evaluation of BRAF V600E levels in cell-free DNA (cfDNA) as a biomarker of response in BRAF V600E mutated radioactive iodine refractory (RAIR) papillary thyroid cancer (PTC) treated with dabrafenib alone or in combination with trametinib. Thyroid 27(S1):A-106, 2017. e-Pub 2017.
- Borregales LD, Adibi M, Thomas AZ, Reis RB, Chery LJ, Devine CE Wang X, Potretzke AM, Potretzke T, Figenshau RS, Bauman TM, Matin SF, Karam JA, Wood CG. Predicting adherent perinephric fat with preoperative clinical and radiological factors in partial nephrectomy: Development and validation of a risk score. J Clin Oncol 34(2S), 2016. e-Pub 2016.
- Adibi M, Kenney P, Thomas AZ, Devine CE, Karam JA, Wood CG. Predicting pulmonary metastases among patients with indeterminate pulmonary nodules with renal cell carcinoma. J Clin Oncol 33(7):352-360, 2015. e-Pub 2015.
- Karam JA, Devine CE, Urbauer DL, Lozano M, Kamran A, Pheroze T, Tannir NM, Wood CG. Phase II trial of neoadjuvant axitinib in patients with locally advanced non-metastatic clear cell renal cell carcinoma. J Clin Oncol 32(4):876-880, 2014. e-Pub 2014.
- Dadu R, Devine CE, Hernandez M, Busaidy N, Waguespack S, Ying A, Habra MA, Thosani S, Hu M, Cabanillas ME. Is second line targeted beneficial in patients (pts) with differentiated thyroid cancer (DTC) after 1st line sorafenib (SOR) failure?. 2013 American Society of Clinical Oncology Annual Meeting, 2013. e-Pub 2013.
- Lorch JH, Busaidy N, Ruan DT, Janne PA, Limaye S, Wirth LJ, Wagle N, Hanna GJ, Misiukiewicz K, Suda M, Haddad TC, Devine CE, Williams A, Warsi G, Posner MR, Haddad RI. A phase II study of everolimus in patients with aggressive RAI refractory (RAIR) thyroid cancer (TC). 2013 American Society of Clinical Oncology Annual Meeting, 2013. e-Pub 2013.
- Karam JA, Devine CE, Lozano M, Tannir NM, Ahrar K, Tamboli P, Wood CG. A phase II clinical trial examining the impact of neoadjuvant axitinib on primary tumor response in patients with locally advanced clear cell renal cell carcinoma. 2013 American Society of Clinical Oncology Annual Meeting, 2013. e-Pub 2013.
- Viswanathan C, Vikram R, Devine CE, Balachandran A, Bronstein Y, Bhosale PR. F18-FDG PET CT in gynecologic malignancies: evidence, pearls, and pitfalls. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2011. e-Pub 2011.
- Bedi D, Patnana M, Gonzalez-DeLuna M, Viswanathan C, Bhosale P, Ernst R, Bronstein Y, Balachandran A, LePetross C, Devine CE, Marcal L, Vikram R, Lem K. Ovarian cancer screening: unmasking the corpus luteum and other actors--how to sort them out. AJR Am J Roentgenol 190(4 Suppl), 2008. e-Pub 2008.
- Costelloe C, Sepulveda K, Devine CE, McAlee K, Kumar R, Madewell J. Imaging characteristics of locally recurrent primary tumors of bone. 90th Scientific Assembly and Annual Meeting of the Radiological Society of North America Program. e-Pub 2004.
Book Chapters
- Vikram R, Patnana M, Devine CE, Mansfield P, Phan A. Part IV: Gastrointestinal tract, gastric carcinoma. In: Oncologic Imaging: A Multidisciplinary Approach, 2022.
- Vikram R, Patnana M, Devine CE, Mansfield P, Phan A. Gastric Carcinoma. In: Oncologic Imaging: A Multidisciplinary Approach. Elsevier, 234-249, 2022.
- Bhosale PR, Devine CE, Gardner CS, Qayyum A. Role computed tomography and magnetic resonance imaging in the evaluation of gynecologic disorders. In: Callen's Ultrasonography in Obstetrics and Gynecology. 6th. Elsevier, 1045-1075, 2016.
- Vikram R, Patnana M, Devine CE, Mansfield P, Phan A. Part IV: Gastrointestinal tract, gastric carcinoma. In: Oncologic Imaging: A Multidisciplinary Approach. Elsevier, 231-246, 2012.
Patient Reviews
CV information above last modified September 10, 2026